Search Browse Earnings

Sonoma Pharmaceuticals, Inc. — SlamSEC

Sonoma Pharmaceuticals, Inc.

Nasdaq:SNOA

Surgical & Medical Instruments & Apparatus·BOULDER, CO

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Trombly Amy Moss

CFO

Dvonch Jerome J

Revenue

$12.7M

-4.0% YoY

FY 2025

Adj. EBITDA

-$4.6M

-35.9% margin

FY 2025

Net Income

-$4.8M

-38.0% margin

FY 2025

EPS (Diluted)

-$10.63

FY 2025

Stock Price

$2.57

+7.9%

2026-03-10

52W Range

$1.75 – $6.92

P/E Ratio

-0.2x

Market Cap

$4.4M

Cash

$3.1M

FY 2025

Total Debt

$1.6M

FY 2022

Net Cash

$1.5M

FY 2022

Enterprise Value

$3.0M

Debt / EBITDA

0.3x

FY 2025

EV / EBITDA

-0.6x

Employees

—